AKBA vs ALLE · rev $102.7M vs P/E 21, rev $2.19B
Akebia Ther (AKBA) versus Allegion PLC (ALLE) — a side-by-side from cached financials, not a winner call.
Akebia Ther (AKBA) is a drug manufacturers - specialty & generic company listed on US.
Allegion PLC (ALLE) is a security & protection services company listed on US.
Latest reported AKBA revenue for 2026-06-30 was $102.7M. Net income was -$18.0M. Revenue was up 91.8% from 2026-03-31 to 2026-06-30. AKBA currently screens at market cap $260.1M.
Latest reported ALLE revenue for 2026-06-30 was $2.19B. Net income was $322.7M. ALLE currently screens at market cap $12.71B and trailing P/E 20.7.
AKBA currently screens at market cap $260.1M. ALLE currently screens at market cap $12.71B and trailing P/E 20.7.
Not investment advice. Open the AKBA and ALLE stock pages for the full models.
Not investment advice.